Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray B Urowitz

Showing results (1-10 of 188) with videos related to

Pageof 19
Sort By:
Current Rheumatology Reviews|July 6, 2017
Cardiovascular and Pulmonary Manifestations of Systemic Lupus ErythematosusKonstantinos Tselios, Murray B Urowitz
Seminars in Arthritis and Rheumatism|April 9, 2008
Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatmentGeorge Steiner, Murray B Urowitz
Rheumatic Diseases Clinics of North America|June 1, 2005
Contributions of observational cohort studies in systemic lupus erythematosus: the university of toronto lupus clinic experienceMurray B Urowitz, Dafna D Gladman
The Journal of Rheumatology|May 3, 2012
University of Toronto Lupus Clinic turns 40Dafna D Gladman, Murray B Urowitz
Current Rheumatology Reports|July 30, 2008
The SLICC inception cohort for atherosclerosisMurray B Urowitz, Dafna D Gladman
Arthritis Care & Research|July 8, 2017
ReplyMurray B Urowitz, Dafna D Gladman
Rheumatic Diseases Clinics of North America|June 1, 2005
Premature atherosclerosis in systemic lupus erythematosusMandana Nikpour, Murray B Urowitz, Dafna D Gladman
Expert Opinion on Biological Therapy|January 24, 2013
Systemic lupus erythematosus: an update on current pharmacotherapy and future directionsZahi Touma, Murray B Urowitz, Dafna D Gladman
Nature Clinical Practice. Rheumatology|August 19, 2007
Should all patients with systemic lupus erythematosus receive cardioprotection with statins?Sergio Toloza, Murray B Urowitz, Dafna D Gladman
The Journal of Rheumatology|May 4, 2005
Adjusted mean Systemic Lupus Erythematosus Disease Activity Index-2K is a predictor of outcome in SLEDominique Ibañez, Dafna D Gladman, Murray B Urowitz
Pageof 19

Showing results (1-10 of 188) with videos related to

Sort By:
Pageof 19
Current Rheumatology Reviews|July 6, 2017
Cardiovascular and Pulmonary Manifestations of Systemic Lupus ErythematosusKonstantinos Tselios, Murray B Urowitz
Seminars in Arthritis and Rheumatism|April 9, 2008
Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatmentGeorge Steiner, Murray B Urowitz
Rheumatic Diseases Clinics of North America|June 1, 2005
Contributions of observational cohort studies in systemic lupus erythematosus: the university of toronto lupus clinic experienceMurray B Urowitz, Dafna D Gladman
The Journal of Rheumatology|May 3, 2012
University of Toronto Lupus Clinic turns 40Dafna D Gladman, Murray B Urowitz
Current Rheumatology Reports|July 30, 2008
The SLICC inception cohort for atherosclerosisMurray B Urowitz, Dafna D Gladman
Arthritis Care & Research|July 8, 2017
ReplyMurray B Urowitz, Dafna D Gladman
Rheumatic Diseases Clinics of North America|June 1, 2005
Premature atherosclerosis in systemic lupus erythematosusMandana Nikpour, Murray B Urowitz, Dafna D Gladman
Expert Opinion on Biological Therapy|January 24, 2013
Systemic lupus erythematosus: an update on current pharmacotherapy and future directionsZahi Touma, Murray B Urowitz, Dafna D Gladman
Nature Clinical Practice. Rheumatology|August 19, 2007
Should all patients with systemic lupus erythematosus receive cardioprotection with statins?Sergio Toloza, Murray B Urowitz, Dafna D Gladman
The Journal of Rheumatology|May 4, 2005
Adjusted mean Systemic Lupus Erythematosus Disease Activity Index-2K is a predictor of outcome in SLEDominique Ibañez, Dafna D Gladman, Murray B Urowitz
Pageof 19